
|Videos|January 13, 2015
How the DEA Holds Pharmacists Accountable for Failing to Verify Controlled Substance Prescriptions for a Legitimate Purpose
Karen Ryle, MS, RPh, associate chief of pharmacy at Massachusetts General Hospital, discusses how the DEA has held pharmacists accountable for failing to verify controlled substance prescriptions for a legitimate medical purpose.
Advertisement
Karen Ryle, MS, RPh, associate chief of pharmacy at Massachusetts General Hospital, discusses how the DEA has held pharmacists accountable for failing to verify controlled substance prescriptions for a legitimate medical purpose.
This interview was recorded at the ASHP 2014 Midyear Clinical Meeting in Anaheim, California.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Enfortumab Vedotin Plus Pembrolizumab Shows Promise as a Platinum-Free Option in Earlier Bladder Cancer
2
FDA Approves Amivantamab and Hyaluronidase-lpuj, Revolutionizing Lung Cancer Treatment With 5-Minute Subcutaneous Delivery
3
How Pharmacists Can Close the Opioid Addiction Care Gap
4
Advancing the Role of Pharmacy Technicians in Hazardous Drug Compounding
5









































































































































































































